175 related articles for article (PubMed ID: 9229983)
1. [The effects of aprotinin. Blood loss and coagulation parameters in orthotopic liver transplantation: A clinical-experimental, prospective and randomized double-blind study].
Kratzer MA; Azad SC; Groh J; Welte M; Haller M; Pratschke E
Anaesthesist; 1997 Apr; 46(4):294-302. PubMed ID: 9229983
[TBL] [Abstract][Full Text] [Related]
2. Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: a prospective, randomized, double-blind study.
Findlay JY; Rettke SR; Ereth MH; Plevak DJ; Krom RA; Kufner RP
Liver Transpl; 2001 Sep; 7(9):802-7. PubMed ID: 11552215
[TBL] [Abstract][Full Text] [Related]
3. Reduction of blood loss and transfusion requirement by aprotinin in posterior lumbar spine fusion.
Lentschener C; Cottin P; Bouaziz H; Mercier FJ; Wolf M; Aljabi Y; Boyer-Neumann C; Benhamou D
Anesth Analg; 1999 Sep; 89(3):590-7. PubMed ID: 10475286
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation.
Ickx BE; van der Linden PJ; Melot C; Wijns W; de Pauw L; Vandestadt J; Hut F; Pradier O
Transfusion; 2006 Apr; 46(4):595-605. PubMed ID: 16584436
[TBL] [Abstract][Full Text] [Related]
5. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
6. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group.
Porte RJ; Molenaar IQ; Begliomini B; Groenland TH; Januszkiewicz A; Lindgren L; Palareti G; Hermans J; Terpstra OT
Lancet; 2000 Apr; 355(9212):1303-9. PubMed ID: 10776742
[TBL] [Abstract][Full Text] [Related]
7. Aprotinin in orthotopic liver transplantation.
García L; Sabaté A; Domenech P; Martinez Brotons F; Drudis R; Jaurrieta E
Transplant Proc; 1995 Aug; 27(4):2290-1. PubMed ID: 7544500
[No Abstract] [Full Text] [Related]
8. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effect of both tranexamic acid and aprotinin on blood loss reduction in reoperative valve replacement surgery.
Jamieson WR; Dryden PJ; O'Connor JP; Sadeghi H; Ansley DM; Merrick PM
Circulation; 1997 Nov; 96(9 Suppl):II-96-100; discussion II-100-1. PubMed ID: 9386082
[TBL] [Abstract][Full Text] [Related]
10. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial.
Hekmat K; Zimmermann T; Kampe S; Kasper SM; Weber HJ; Geissler HJ; Mehlhorn U
Curr Med Res Opin; 2004 Jan; 20(1):121-6. PubMed ID: 14741082
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of single-dose aprotinin 2 million KIU in reducing blood loss and its impact on the incidence of deep venous thrombosis in patients undergoing total hip replacement surgery.
Hayes A; Murphy DB; McCarroll M
J Clin Anesth; 1996 Aug; 8(5):357-60. PubMed ID: 8832445
[TBL] [Abstract][Full Text] [Related]
12. Aprotinin reduces blood loss in patients undergoing elective liver resection.
Lentschener C; Benhamou D; Mercier FJ; Boyer-Neumann C; Naveau S; Smadja C; Wolf M; Franco D
Anesth Analg; 1997 Apr; 84(4):875-81. PubMed ID: 9085974
[TBL] [Abstract][Full Text] [Related]
13. Aprotinin in orthotopic liver transplantation: evidence for a prohemostatic, but not a prothrombotic, effect.
Molenaar IQ; Legnani C; Groenland TH; Palareti G; Begliomini B; Terpstra OT; Porte RJ
Liver Transpl; 2001 Oct; 7(10):896-903. PubMed ID: 11679989
[TBL] [Abstract][Full Text] [Related]
14. Aprotinin does not diminish blood loss in elective operations for infrarenal abdominal aneurysms: a randomized double-blind controlled trial.
Leijdekkers VJ; Vahl AC; Mackaay AJ; Huijgens PC; Rauwerda JA
Ann Vasc Surg; 2006 May; 20(3):322-9. PubMed ID: 16779513
[TBL] [Abstract][Full Text] [Related]
15. The prophylactic effect of aprotinin on intraoperative bleeding in liver transplantation: a randomized clinical study.
García-Huete L; Domenech P; Sabaté A; Martínez-Brotons F; Jaurrieta E; Figueras J
Hepatology; 1997 Nov; 26(5):1143-8. PubMed ID: 9362354
[TBL] [Abstract][Full Text] [Related]
16. Reduction of blood loss using high-dose aprotinin in major orthopaedic surgery: a prospective, double-blind, randomised and placebo-controlled study.
Jeserschek R; Clar H; Aigner C; Rehak P; Primus B; Windhager R
J Bone Joint Surg Br; 2003 Mar; 85(2):174-7. PubMed ID: 12678347
[TBL] [Abstract][Full Text] [Related]
17. Aprotinin (Trasylol) does not reduce bleeding in primary total hip arthroplasty.
Langdown AJ; Field J; Grote J; Himayat H
J Arthroplasty; 2000 Dec; 15(8):1009-12. PubMed ID: 11112196
[TBL] [Abstract][Full Text] [Related]
18. Does aprotinin really reduce blood loss in orthotopic liver transplantation?
Groh J; Welte M; Azad SC; Anthuber M; Haller M; Kratzer MA
Semin Thromb Hemost; 1993; 19(3):306-8. PubMed ID: 7689758
[No Abstract] [Full Text] [Related]
19. Prospective randomized placebo-controlled trial of aprotinin for elective aortic reconstruction.
Ranaboldo CJ; Thompson JF; Davies JN; Shutt AM; Francis JN; Roath OS; Webster JH; Chant AD
Br J Surg; 1997 Aug; 84(8):1110-3. PubMed ID: 9278654
[TBL] [Abstract][Full Text] [Related]
20. Changes in the contact system during orthotopic liver transplantation with and without aprotinin.
Segal HC; Hunt BJ; Cottam S; Beard C; Francis JL; Potter D; Tan KC
Transplantation; 1995 Feb; 59(3):366-70. PubMed ID: 7532878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
